Hongene is thrilled to announce our participation in RNA Leaders Europe Congress 2025. The RNA Leaders program features scientific tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum.
mRNA Therapeutic & Vaccines
- Clinical data beyond infectious disease areas such as oncology & rare diseases
- Evaluate mRNA 2.0 modalities – circular RNAs, self-amplifying RNAs and self-replicating RNAs.
Oligo-Based RNA Therapeutics
- Development of ASOs and siRNA into the clinic
- Improve understanding for neurological cardiometabolic and rare diseases
Next-Generation RNA
- RNA editing and RNA cell therapy applications
- Evaluate POCs of regRNAs, tRNAs and other non-coding
- Re-emergence of microRNAs applications
Targeted Delivery
- Novel modifications of LNPs of mRNA therapeutics
- Expansion delivery solutions for short RNAs of conjugates and peptides
- Addressing tissue and cell specificity
Manufacturing and Analytics RNA Medicines
- New RNA biomarkers and analytics
- Improved CMC strategies
- Sustainable raw materials and equipment
Discovery and Target Selection
- AI-based drug discovery and targets
- Understanding RNA biological MOAs
- Enhanced RNA characterization tools
Welcome to visit our booth. Let’s discuss how Hongene’s high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.